Industry news

Start-up pushes for artificial intelligence to support medical diagnostics

Marchmont Innovation News

eleMD, a Russian start-up, is developing a software platform that uses artificial intelligence (AI) for cancer diagnostics and prognostication. Over the past few months the start-up has been focused on fine-tuning the platform’s image recognition functionality for cancer diagnostics, and also on making the solution scalable for medical specialists from across disciplines to be able to analyze heterogeneous medical data. 
 

Small biotech companies rule in development of microbiome-targeted therapeutics

GMP News

According to leading data and analytics company GlobalData, with smaller biotech companies dominating the pipeline for microbiome-targeted therapeutics, large pharma firms, such as Johnson & Johnson, are eager to collaborate with biotech companies and academic labs to further the development of microbiome-targeted therapeutics in immunology.

Can CAR-T and gene therapy cures really sustain biopharma? Not for all, analyst says

Arlene Weintraub / FierceBiotech

Ever since 2012 when Novartis invested in personalized CAR-T cancer treatments being developed at the University of Pennsylvania, analysts have pondered a difficult question: How can pharma companies profit from curing patients?

SID & GP: many Russian pharma companies outdo their foreign counterparts

GMP News

According to Vladimir Orlov, Deputy Head of the Educational Center for Good Practices, State Institute of Drugs and Good Practices (SID & GP), a federal budgetary institution, the inspections and checks conducted in major foreign pharmaceutical companies have a great importance for the development of Russian drug manufacturing industry.

Will Facebook’s data-scraping woes bleed into healthcare and pharma?

Beth Snyder Bulik / FiercePharma

Another internet data scandal—this time Facebook and Cambridge Analytica—has consumers buzzing about the safety of their personal information. Will people become more nervous about sharing their healthcare data in its wake?

EMA published report on the International API inspection programme

GMP News

The European Medicines Agency (EMA) and its European and international partners have successfully strengthened their interactions to improve the oversight of active pharmaceutical ingredient (API) manufacturers worldwide, as highlighted in the International API inspection programme report for 2011-2016.

The Government of India submitted a draft amendment on cell therapies

GMP News

The Ministry of Health and Family Welfare of India, after consultations with the Drugs Technical Advisory Board (DTAB), has proposed a draft amendment to the Drugs and Cosmetics Rules, 1945, that defines stem cell-based products (SCBP) to streamline the regulatory framework for advanced research and regenerative therapies in this rapidly growing field.

New production sites can boost output of medicines in St. Petersburg

GMP News

St. Petersburg authorities expect that this year the pharmaceutical industry in the city will grow by 20%. This growth will be driven by new production sites and expanding output at existing plants.

Get ready, Pfizer HQ staffers: You’re moving on up to a slick new Spiral skyscraper

Tracy Staton / FiercePharma

It’s official: Pfizer’s New York headquarters will move to Hudson Yards and its slick new skyscraper, The Spiral. Left behind will be the 42nd Street building Pfizer has called home since 1961, but few employees are likely to be heartbroken when they set up their desks in the new building.

State Duma deputies propose to simplify registration of Russian medicines

GMP News

The issues of legislative regulation and simplification of drug registration procedures were discussed by participants of the roundtable held on April 9 in the Russian State Duma.